Despite the widespread clinical application of associated biomarkers, such as α-fetoprotein (AFP), for the diagnosis of hepatocellular carcinoma (HCC), their use remains controversial and constrained by limitations (5). The gene discussed is AFP; the disease is hepatocellular carcinoma.